"Issues with the re-examination system having both a function of ensuring the safety of medicinal products and a function of data protection - The necessity to redesign the re-examination system from both pharmaceutical and IP perspectives -"
placeThe client company (a pharmaceutical company, listed on the Prime Market of Tokyo Stock Exchange)